Evidence map›Paper›PMID 40565562›Full record

ArticleGenes2025

A Novel Recurrent 200 kb

Guadalupe A Cifuentes, Marta Diñeiro, Alicia R Huete, Raquel Capín, Adrián Santiago, Alberto A R Vargas, Dido Carrero, Esther López Martínez, Beatriz Aguiar, Anja Fischer and 4 more

Abstract read
In one paragraph

Article in Genes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Recent Progress in Mechanism-Based Therapies forInternational journal of molecular sciences · 2026
    Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Guadalupe A CifuentesFundación Centro Médico de Asturias, 33193 Oviedo, Spain.ORCID 0000-0002-0042-0051
Marta DiñeiroInstituto de Medicina Oncológica y Molecular de Asturias (IMOMA), 33193 Oviedo, Spain.
Alicia R HueteFundación Centro Médico de Asturias, 33193 Oviedo, Spain.
Raquel CapínInstituto de Medicina Oncológica y Molecular de Asturias (IMOMA), 33193 Oviedo, Spain.ORCID 0000-0001-7812-4861
Adrián SantiagoFundación Centro Médico de Asturias, 33193 Oviedo, Spain.ORCID 0009-0008-7869-1637
Alberto A R VargasFundación Centro Médico de Asturias, 33193 Oviedo, Spain.
Dido CarreroFundación Centro Médico de Asturias, 33193 Oviedo, Spain.
Esther López MartínezInstituto de Medicina Oncológica y Molecular de Asturias (IMOMA), 33193 Oviedo, Spain.
Beatriz AguiarHospital Centro Médico de Asturias, 33193 Oviedo, Spain.
Anja FischerInstitute of Molecular Oncology and Functional Genomics, School of Medicine, Technische Universität München, 81675 Munich, Germany.
Roland RadInstitute of Molecular Oncology and Functional Genomics, School of Medicine, Technische Universität München, 81675 Munich, Germany.
María CostalesHospital Universitario Central de Asturias, 33011 Oviedo, Spain.
Rubén CabanillasInstituto de Medicina Oncológica y Molecular de Asturias (IMOMA), 33193 Oviedo, Spain.
Juan CadiñanosFundación Centro Médico de Asturias, 33193 Oviedo, Spain.ORCID 0000-0001-7561-7759

Funding

Fundación María Cristina Masaveu Peterson NA
6 · The paper itself

Abstract

BACKGROUND/

objectivesPathogenic recessive

methodsWe used panel NGS sequencing to detect the deletion, MLPA to validate it, whole-genome sequencing to map its breakpoints, PCR + Sanger sequencing to finely characterize it and triple-primer PCR to screen for it.

resultsWe identified a novel 200 kb deletion spanning the whole

conclusionsThis work highlights the importance of comprehensively testing all genomic regions known to be clinically relevant for a given genetic condition, including thorough

Indexed as

Connexin 26Hearing Loss, SensorineuralSequence DeletionAdultDeafnessFemaleHeterozygoteHumansMaleSpainConnexin 26GJB2 protein, humancis-regulationCRYL1DFNB1Agenetic diagnosticsGJB2hereditary hearing losslarge deletions

Identifiers

PMID40565562
PMCPMC12191918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.